SwingTradeWith all due respect, your comments are a bit vague...

SwingTrade

With all due respect, your comments are a bit vague and not particularly helpful even from a perspective of objective criticism.

You’ve given no example of these other countries and their cough algorithms. You fail to note that Resapp has an incredible library of pre covid coughs to help ascertain the impact in the lungs. Not to mention we already have regulatory approval for a host of respiratory diseases.

While there are still some hurdles to cross (double blind clinical trials for COVID screening), RAP are far ahead of most in development, commercialisation and accuracy. There’s a reason Pfizer want to buy RAP.

Kind of agree with TT. We all have differences of opinion regarding vaccines etc…but it’d be great to keep this forum focused on what we have in common, RAP